UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹1150 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 4.29% | 3.69% |
6 Month | -1.25% | -2.83% |
1 Year | 14.35% | 20.61% |
3 Year | 22.38% | 23.17% |
5 Year | 22.41% | 22.3% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | -0.97% | -2.51% |
1 Year | -2.86% | -2.71% |
3 Year | 21.3% | 23.45% |
5 Year | 17.98% | 18.43% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 18.19% | 11.43% |
3 Year | 20.5% | 16.02% |
5 Year | 20.36% | 14.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.623% | 16.371% |
Sharp | 0.707% | 0.731% |
Beta | 0.908% | 0.958% |
Alpha | 0.486% | 0.84% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.36 | 1.35 |
Large Cap | 38.72 | 28.87 |
Mid Cap | 32.78 | 26.26 |
Small Cap | 27.14 | 43.53 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.36 | 0.45 |
Healthcare | 98.64 | 98.22 |
Basic Materials | - | 1.33 |
Top Comparisons
Mahindra Manulife Liquid Fund - Regular Plan - Growth
3Y Returns6.88%
Mirae Asset Liquid Fund - Growth
3Y Returns6.85%
SBI Flexicap Fund - REGULAR PLAN -Growth Option
3Y Returns15.22%
LIC MF Flexi Cap Fund-Growth
3Y Returns15.04%
Tata Small Cap Fund Regular Growth
3Y Returns23.61%
PGIM India Small Cap Fund - Regular Plan - Growth Option
3Y Returns14.85%
Kotak Credit Risk Fund - Growth
3Y Returns6.82%
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option
3Y Returns7.73%